PatientsVille.com Logo

CONTUSION and Ranitidine

PatientsVille

CONTUSION Symptoms and Causes

A bruise is a mark on your skin caused by blood trapped under the surface. It happens when an injury crushes small blood vessels but does not break the skin. Those vessels break open and leak blood under the skin.

Bruises are often painful and swollen. You can get skin, muscle and bone bruises. Bone bruises are the most serious.

It can take months for a bruise to fade, but most last about two weeks. They start off a reddish color, and then turn bluish-purple and greenish-yellow before returning to normal. To reduce bruising, ice the injured area and elevate it above your heart. See your healthcare provider if you seem to bruise for no reason, or if the bruise appears to be infected.

Check out the latest treatments for CONTUSION

CONTUSION treatment research studies

Ranitidine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Ranitidine Side Effects

Dyspnoea (125)
Anaphylactic Reaction (77)
Hypotension (71)
Diarrhoea (67)
Nausea (65)
Vomiting (62)
Urticaria (59)
Abdominal Pain (46)
Dizziness (43)
Malaise (43)
Cardiac Arrest (40)
Pain (39)
Loss Of Consciousness (37)
Fatigue (36)
Angioedema (35)
Confusional State (34)
Renal Failure Acute (33)
Pruritus (32)
Headache (32)
Chest Pain (31)
Abdominal Pain Upper (29)
Overdose (27)
Bradycardia (27)
Rash (27)
Pyrexia (25)
Hypersensitivity (24)
Dyspepsia (23)
Circulatory Collapse (23)
Chest Discomfort (22)
Erythema (21)
Thrombocytopenia (21)
Gastrooesophageal Reflux Disease (21)
Product Quality Issue (21)
Weight Decreased (20)
Burning Sensation (20)
Alanine Aminotransferase Increased (20)
Paraesthesia (20)
Cholelithiasis (20)
Dysgeusia (19)
Neutropenia (19)
Cough (19)
Flushing (19)
Hypertension (19)
Tubulointerstitial Nephritis (18)
Condition Aggravated (17)
Feeling Abnormal (17)
Depression (17)
Vision Blurred (17)
Agitation (16)
Heart Rate Increased (16)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

CONTUSION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel
Conditions: Muscular Atrophy;   Sprains;   Tendonitis
Interventions: Drug: Ibuprofen;   Drug: Profenid
Outcome Measures: Clinical study evaluating the efficacy and safety of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, Contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. ";   Clinical study evaluating the tolerability of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, Contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. "
2 Unknown  Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma
Conditions: Blunt Chest Trauma;   Acute Respiratory Distress Syndrome
Interventions: Drug: standard care treatment;   Drug: Celecoxib;   Drug: Rosuvastatin;   Drug: Combined therapy
Outcome Measure: 1. Signs of ALI, i.e., pneumonia, adult respiratory distress syndrome [ARDS]
3 Unknown  To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.
Conditions: Contusions;   Sprains;   Trauma;   Muscle Injury;   Myalgia;   Myofascial Pain;   Tendinitis
Interventions: Drug: Aliviador;   Drug: Gelol
Outcome Measures: To evaluate the efficacy in reducing signs and symptoms Aliviador compared to Gelol.;   To evaluate the tolerability use Aliviador compared to Gelol.
4 Unknown  Efficacy and Safety of Salonsip Compared to Sabiá Plaster
Conditions: Contusions;   Sprains;   Myalgia;   Pain;   Tendonitis
Interventions: Drug: Salonsip plaster;   Drug: Sabia plaster
Outcome Measures: Likert Scales and Visual Analogue Scales;   Safety evaluation by adverse events relate.
5 Unknown  Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
Conditions: Traumatic Brain Injury;   Subdural Hematoma;   Cerebral Contusion;   Head Injury;   Cerebral Edema
Interventions: Drug: Induced, sustained hypernatremia using hypertonic saline;   Drug: Standard of care (hypertonic saline and mannitol; serum sodium)
Outcome Measures: Primary Efficacy Objective;   Primary Safety Objective;   Short term neurological outcome
6 Unknown  Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols
Conditions: Sprains and Strains;   Contusions
Interventions: Drug: etoricoxib 90mg 14 days;   Drug: etoricoxib 60mg daily for 14 days
Outcome Measures: Reduction of pain during active mobilization measured using a visual analogue scale VAS at day 8;   Volumetric measurement of the ankle and foot;   Pain during motion against resistance;   Functional impairment and global assessment of efficacy by either patient and investigator;   Tolerability will be assessed by the frequency of adverse experiences and global assessment of efficacy by either patient and investigator
7 Unknown  The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients
Condition: Traumatic Brain Injury
Interventions: Drug: D-cycloserine;   Drug: placebo
Outcome Measures: A battery of neuropsychological tests at 3 and 6 months post-injury;   Glasgow Outcome Score - Extended (GOS-E)
8 Not yet recruiting Great Saphenous Vein Electrocoagulation
Conditions: Venous Disease;   Varicose Veins
Interventions: Device: GSV Electrocoagulation;   Device: GSV Radiofrequency
Outcome Measures: GSV occlusion;   Pain VAS;   Post operative bruising;   Post operative sensory abnormality;   Venous Clinical Severity Score (VCSS);   Aberdeen Varicose Vein Questionnaire (AVVQ);   Deep Venous Thrombosis (DVT);   Clinical Etiology Anatomy Pathophysiology (CEAP)
9 Not yet recruiting DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
Condition: Postoperative Ecchymosis
Intervention: Drug: DDAVP
Outcome Measures: Reduction in Ecchymosis and Swelling;   Patient Behavior Factors
10 Recruiting Attention Intervention Management
Conditions: Traumatic Brain Injury (TBI);   Attention Deficit Hyperactivity Disorder (ADHD);   Head Injury;   Brain Concussion;   Head Injuries, Closed
Intervention: Behavioral: AIM
Outcome Measures: Parent Report Measures;   Teacher Report Measures
11 Recruiting Internet-based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT)--RRTC
Condition: Traumatic Brain Injury
Interventions: Behavioral: Internet-based Interacting Together Everyday: Recovery After Childhood TBI (I-InTERACT);   Behavioral: Internet-based-Interacting Together Everyday, Recovery after Childhood TBI Express (I-InTERACT Express);   Behavioral: Internet Resources Comparison (IRC)
Outcome Measures: Parent Report Measures;   Neuropsychological Testing
12 Recruiting Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions--Teen Online Problem Solving Study
Condition: Traumatic Brain Injury
Interventions: Behavioral: Teen Online Problem Solving (TOPS);   Behavioral: Teen Online Problem Solving--Teen Only (TOPS-TO);   Behavioral: Internet Resources Comparison (IRC)
Outcome Measures: Parent Report Measures;   Teen Self-Report Measures;   Neuropsychological Testing
13 Recruiting Clinical Study Comparing the Efficacy of Transbuccal Paracetamol 125 mg Versus Paracetamol Injection 1g in Slow Infusion IV in Patients With Acute Pain
Condition: Acute Pain
Interventions: Drug: paracetamol;   Drug: Placebo
Outcome Measure: Pain score measured by visual analogue scale
14 Unknown  Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift
Condition: Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant
Intervention: Drug: Fibrin Sealant (Artiss)
Outcome Measures: Comparison of ecchymosis and edema;   Resolution of ecchymosis and edema, incidence of hematoma/seroma
15 Recruiting A Study of Nutritional Supplementation in Altering Ecchymosis, Erythema and Health Outcomes Associated With Aesthetic Procedures
Condition: Ecchymosis and Erythema Commonly Associated With Soft Tissue Filler Injections and Facial Ablative Laser Resurfacing Treatments.
Intervention: Dietary Supplement: Multizyme Cellular Vitality Cyruta Plus SHEP
Outcome Measures: Canfield Vectra Photography;   Heatherton & Polivy State Self-Esteem (HPSS) Scale, (SkinReplica) at Day 30 as compared to baseline (ablative laser group only, Global Aesthetic Improvement Scale (GAIS,
16 Recruiting Prospective Observation of Wound Healing With Prevena Incision Management System
Condition: Scarring
Intervention: Device: Prevena
Outcome Measure: Scarring
17 Recruiting Gene Therapy for Wiskott-Aldrich Syndrome
Condition: Wiskott-Aldrich Syndrome
Intervention: Genetic: Autologous CD34 positive cells transduced with WAS encoding lentiviral vector.
Outcome Measures: Conditioning regimen-related safety;   Safety of lentivirus gene transfer into HSC;   Sustained engraftment of genetically corrected haematopoietic stem cells in peripheral blood and/or in bone marrow;   Expression of vector-derived WASP;   Improved T-cell functions;   Antigen-specific responses to vaccination;   Improved platelet count;   Lack of immune response to transgene;   Reduced frequency of severe infections;   Reduced bruising and bleeding episodes;   Reduced autoimmunity phenomena and eczema;   Improved quality of life
18 Not yet recruiting Efficacy of Arnica D1 Ointment After Upper Blepharoplasty
Conditions: Blepharoplasty;   Upper Eyelid Blepharoplasty
Interventions: Drug: Arnica;   Drug: Placebo ointment
Outcome Measures: Surgical outcome;   amount of tissue swelling; redness; pain; postoperative recovery; patient satisfaction
19 Recruiting STOPAIN in the Treatment of a Single Migraine Attack
Condition: Migraine
Intervention: Drug: STOPAIN topical gel
Outcome Measures: Efficacy of STOPAIN in the Acute Treatment of Migraine;   evaluate the tolerability, safety, and sustained pain freedom of STOPAIN
20 Not yet recruiting Evaluation of Wound Drainage After Knee or Hip Arthroplasty
Condition: Complications; Arthroplasty
Interventions: Drug: Rivaroxaban (Xarelto);   Drug: Warfarin (Coumadin)
Outcome Measures: Number of days until a dry wound;   Amount and character of wound drainage;   Number of days in the hospital postoperatively.;   Incidence of wound infection;   Incidence of additional operations